TELA Bio (TELA) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182.39% |
| Dec 31, 2025 | 305.46% |
| Sep 30, 2025 | -83.05% |
| Jun 30, 2025 | -49.32% |
| Mar 31, 2025 | -36.32% |
| Dec 31, 2024 | 553.73% |
| Sep 30, 2024 | -318.54% |
| Jun 30, 2024 | -80.05% |
| Mar 31, 2024 | -23.82% |
| Dec 31, 2023 | -38.20% |
| Sep 30, 2023 | -23.63% |
| Jun 30, 2023 | 1,173.64% |
| Mar 31, 2023 | -78.04% |
| Dec 31, 2022 | -38.61% |
| Sep 30, 2022 | 1,611.09% |
| Jun 30, 2022 | -115.36% |
| Mar 31, 2022 | -50.05% |
| Dec 31, 2021 | -27.52% |
| Sep 30, 2021 | -20.69% |
| Jun 30, 2021 | -16.13% |
| Mar 31, 2021 | -14.96% |
| Dec 31, 2020 | -12.97% |
| Sep 30, 2020 | -11.15% |
| Jun 30, 2020 | 161.70% |
| Mar 31, 2020 | -21.75% |
| Dec 31, 2019 | 119.30% |
| Sep 30, 2019 | -4.33% |
| Jun 30, 2019 | -5.46% |
| Mar 31, 2019 | -5.75% |
| Dec 31, 2018 | -7.25% |